Effect of food on nifedipine sustained-release preparation. 1989

K Ueno, and S Kawashima, and K Uemoto, and T Ikada, and K Miyai, and K Wada, and K Yamazaki, and K Matsumoto, and I Nakata
Department of Pharmacy, National Sanatorium Sengokuso Hospital, Kaizuka-shi, Japan.

The effect of food on the bioavailability of a nifedipine sustained-release preparation was studied. Each of seven male volunteers received a single oral 20 mg dose with 100 mL of water under two conditions, fasting and after a meal, with a crossover after a seven-day wash-out period. Blood samples were drawn at time zero (just prior to dose), and 1, 2, 3, 4, 6, 8, 10, and 12 hours after dosing. Nifedipine assays were performed by gas chromatography. The area under the serum concentration-time curve (AUC) from 0 to 12 hours and maximum serum concentration (Cmax) were significantly increased by food. Blood pressure was significantly decreased by food. The mean AUC for fasting and meal conditions were 315.0 and 411.4 ng.h/mL, and the mean Cmax were 42.6 and 86.6 micrograms/mL, respectively. The results indicate that food may increase the bioavailability of nifedipine sustained-release preparation.

UI MeSH Term Description Entries
D008297 Male Males
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D005502 Food Substances taken in by the body to provide nourishment. Foods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

K Ueno, and S Kawashima, and K Uemoto, and T Ikada, and K Miyai, and K Wada, and K Yamazaki, and K Matsumoto, and I Nakata
June 2000, Drug development and industrial pharmacy,
K Ueno, and S Kawashima, and K Uemoto, and T Ikada, and K Miyai, and K Wada, and K Yamazaki, and K Matsumoto, and I Nakata
January 1996, Yao xue xue bao = Acta pharmaceutica Sinica,
K Ueno, and S Kawashima, and K Uemoto, and T Ikada, and K Miyai, and K Wada, and K Yamazaki, and K Matsumoto, and I Nakata
September 1985, Chemical & pharmaceutical bulletin,
K Ueno, and S Kawashima, and K Uemoto, and T Ikada, and K Miyai, and K Wada, and K Yamazaki, and K Matsumoto, and I Nakata
January 1986, Journal of pharmaceutical sciences,
K Ueno, and S Kawashima, and K Uemoto, and T Ikada, and K Miyai, and K Wada, and K Yamazaki, and K Matsumoto, and I Nakata
April 1984, The Medical journal of Australia,
K Ueno, and S Kawashima, and K Uemoto, and T Ikada, and K Miyai, and K Wada, and K Yamazaki, and K Matsumoto, and I Nakata
March 1990, Journal of pharmaceutical sciences,
K Ueno, and S Kawashima, and K Uemoto, and T Ikada, and K Miyai, and K Wada, and K Yamazaki, and K Matsumoto, and I Nakata
December 1996, Internal medicine (Tokyo, Japan),
K Ueno, and S Kawashima, and K Uemoto, and T Ikada, and K Miyai, and K Wada, and K Yamazaki, and K Matsumoto, and I Nakata
January 1971, Scandinavian journal of haematology,
K Ueno, and S Kawashima, and K Uemoto, and T Ikada, and K Miyai, and K Wada, and K Yamazaki, and K Matsumoto, and I Nakata
January 1983, Drug intelligence & clinical pharmacy,
K Ueno, and S Kawashima, and K Uemoto, and T Ikada, and K Miyai, and K Wada, and K Yamazaki, and K Matsumoto, and I Nakata
July 1987, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!